• Impact of vascular biology in treatment of cardiovascular disease
Section IV: Antithrombotic interventions in acute coronary syndromes
The VBWG Core Curriculum 2002 slide lecture program, Impact of vascular biology in treatment of cardiovascular disease, covers basic science and clinical advances in vascular biology in a spectrum of disorders. The material is presented in four sections:
This is the 4th and final section of the Core Curriculum 2002. The slides and accompanying notes in this section encompass the epidemiology, pathophysiology, and management of the acute coronary syndromes. The issues that are addressed include:
- The important role of antithrombotic therapy in patient management
- Emerging differences within antithrombotic classes
- New combinations of pharmacologic and mechanical reperfusion regimens
Download S001.ppt (2 slides - 0.3MB)
Section B: Science update
Download S002.ppt (6 slides - 0.8MB)
Section C: Clinical trial update: Oral antiplatelet therapy
Download S003.ppt (3 slides - 0.5MB)
Section D: Clinical trial update: GP IIb/IIIa inhibition
Download S004.ppt (17 slides - 2.8MB)
Section E: Clinical trial update: Heparins
Download S005.ppt (27 slides - 4.0MB)
Section F: Clinical guidelines
Download S006.ppt (9 slides - 1.5MB)
Published by Medical Education Consultants, Inc. (MEDCON), on behalf of the University of Florida College of Medicine.
The editorial content of this program does not necessarily reflect the views or recommendations of the University of Florida College of Medicine, AstraZeneca, Aventis Pharmaceuticals, Monarch Pharmaceuticals, Pfizer Inc, or Wyeth Pharmaceuticals.
This program was prepared and produced by Medical Education Consultants Inc, Westport, Connecticut, on behalf of the University of Florida College of Medicine through an unrestricted educational grant provided by AstraZeneca, Aventis Pharmaceuticals, Monarch Pharmaceuticals, Pfizer Inc, and Wyeth Pharmaceuticals.
©2002 Medical Education Consultants, Inc. (MEDCON). All rights reserved.